Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical ...
Zacks Investment Research on MSN
LLY hits another record high: Is the stock too expensive to buy now?
Eli Lilly LLY shares climbed to another all-time high of $1,235.56, pushing the drugmaker's market capitalization to roughly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results